Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Furin

Showing results (11-20 of 157) with videos related to

Pageof 16
Sort By:
Lancet (London, England)|December 15, 2022
Celebrating choice in the care of people living with drug-resistant tuberculosisAnja Reuter, Jennifer Furin
The Lancet. Infectious Diseases|May 25, 2025
Is shorter the solution for tuberculosis treatment?Rosa Herrera, Jennifer Furin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2020
Treating Drug-resistant Tuberculosis Infection: No More ExcusesAnja Reuter, Jennifer Furin
The Lancet. Infectious Diseases|February 13, 2019
Universal regimens or universal access to drug susceptibility testing for tuberculosis?Rebecca Acquah, Jennifer Furin
Lancet (London, England)|September 16, 2023
Beyond individual inclusion, investment in affected communities is needed to end tuberculosisBusisiwe Beko, Jennifer Furin
The Lancet. HIV|March 5, 2016
The tuberculosis emergency in eastern EuropeJennifer Furin, Petros Isaakidis
The Lancet. Infectious Diseases|March 26, 2023
Balancing adjunctive therapy for tuberculosis treatmentNorbert Ndjeka, Jennifer Furin
The Lancet. Child & Adolescent Health|February 20, 2025
Urgently expanding access to improved treatment for children with multidrug-resistant tuberculosisNishesh Tiwari, Jennifer Furin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2017
To Test or Not to Test? Ending the Age-Old Debate for Drug-Resistant TuberculosisJennifer Furin, Helen Cox
The Lancet. Respiratory Medicine|July 14, 2018
Bedaquiline use in South Africa reveals a lifesaving policy in actionAnja Reuter, Jennifer Furin
Pageof 16

Showing results (11-20 of 157) with videos related to

Sort By:
Pageof 16
Lancet (London, England)|December 15, 2022
Celebrating choice in the care of people living with drug-resistant tuberculosisAnja Reuter, Jennifer Furin
The Lancet. Infectious Diseases|May 25, 2025
Is shorter the solution for tuberculosis treatment?Rosa Herrera, Jennifer Furin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2020
Treating Drug-resistant Tuberculosis Infection: No More ExcusesAnja Reuter, Jennifer Furin
The Lancet. Infectious Diseases|February 13, 2019
Universal regimens or universal access to drug susceptibility testing for tuberculosis?Rebecca Acquah, Jennifer Furin
Lancet (London, England)|September 16, 2023
Beyond individual inclusion, investment in affected communities is needed to end tuberculosisBusisiwe Beko, Jennifer Furin
The Lancet. HIV|March 5, 2016
The tuberculosis emergency in eastern EuropeJennifer Furin, Petros Isaakidis
The Lancet. Infectious Diseases|March 26, 2023
Balancing adjunctive therapy for tuberculosis treatmentNorbert Ndjeka, Jennifer Furin
The Lancet. Child & Adolescent Health|February 20, 2025
Urgently expanding access to improved treatment for children with multidrug-resistant tuberculosisNishesh Tiwari, Jennifer Furin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2017
To Test or Not to Test? Ending the Age-Old Debate for Drug-Resistant TuberculosisJennifer Furin, Helen Cox
The Lancet. Respiratory Medicine|July 14, 2018
Bedaquiline use in South Africa reveals a lifesaving policy in actionAnja Reuter, Jennifer Furin
Pageof 16